Stockreport

Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression [Yahoo! Finance]

Alto Neuroscience, Inc.  (ANRO) 
PDF MOUNTAIN VIEW, Calif., January 14, 2026 BUSINESS WIRE )--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the develo [Read more]